Protagonist Pictures will launch Stan Original rom-com 'One More Shot' for international sales at this year's European Film ...

Truist Securities reiterated its Buy rating and $60.00 price target for Protagonist Therapeutics (NASDAQ:PTGX) shares, which currently trade at $38.78 with a market capitalization of $2.3 billion. The ...

周五，Truist Securities重申了对Protagonist Therapeutics (NASDAQ: PTGX )的买入评级和60.00美元的目标价。该公司目前股价为38.78美元，市值23亿美元。分析师强调了该公司药物候选者rusfertide在治疗真性红细胞增多症（PV，一种血液癌症）方面的潜力。根据InvestingPro数据，该公司保持着优秀的财务健康状况，盈利能力指标强劲。

In a report released today, Tara Bancroft from TD Cowen maintained a Buy rating on Protagonist Therapeutics (PTGX – Research Report), with a ...

In a report released today, Srikripa Devarakonda from Truist Financial maintained a Buy rating on Protagonist Therapeutics (PTGX – Research ...

Protagonist Pictures is launching world sales at the EFM on Australian filmmaker Nicholas Clifford time travelling romantic ...

Protagonist Pictures is launching world sales at the EFM on time travel romantic comedy One More Shot, starring American Gods’ Emily Browning, ahead of its world premiere at SXSW. Australian filmmaker ...

JMP Securities reiterated its Market Outperform rating on Protagonist Therapeutics (NASDAQ:PTGX) with a steady price target ...